Proven efficacy of combined androgen depletion therapy.

Suppr

超能文献

作者信息

Akaza Hideyuki

机构信息

Research Center for Advanced Science and Technology, The University of Tokyo, Komaba, Meguroku, Tokyo, 053-8904, Japan.

出版信息

Curr Urol Rep. 2010 Jul;11(4):221-3. doi: 10.1007/s11934-010-0117-5.

DOI:10.1007/s11934-010-0117-5

PMID:20461479

Abstract

摘要

相似文献

Proven efficacy of combined androgen depletion therapy.

Curr Urol Rep. 2010 Jul;11(4):221-3. doi: 10.1007/s11934-010-0117-5.

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel.

Front Pharmacol. 2017 Nov 22;8:836. doi: 10.3389/fphar.2017.00836. eCollection 2017.

Additive effect of zoledronic acid on serum prostate-specific antigen changes for hormone-sensitive prostate cancer patients with bone metastasis treated by combined androgen blockade.

Int J Urol. 2012 Feb;19(2):169-73. doi: 10.1111/j.1442-2042.2011.02914.x. Epub 2011 Nov 29.

[Chemotherapy combined with androgen-deprivation therapy in high-volume metastatic hormone sensitive prostate cancer: a short-term efficacy and safety analysis].

Zhonghua Wai Ke Za Zhi. 2019 Jun 1;57(6):418-421. doi: 10.3760/cma.j.issn.0529-5815.2019.06.005.

In situ vaccination combined with androgen ablation and regulatory T-cell depletion reduces castration-resistant tumor burden in prostate-specific pten knockout mice.

Cancer Res. 2010 May 1;70(9):3473-82. doi: 10.1158/0008-5472.CAN-09-2490. Epub 2010 Apr 20.

Critical role for p27Kip1 in cell cycle arrest after androgen depletion in mouse mammary carcinoma cells (SC-3).

Oncogene. 1998 Nov 19;17(20):2619-27. doi: 10.1038/sj.onc.1202193.

High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.

Eur Urol. 2015 Jun;67(6):1177-1185. doi: 10.1016/j.eururo.2014.08.053. Epub 2014 Sep 12.

Androgen induced norepinephrine release from postganglionic neurons mediates accessory sex organ smooth muscle proliferation.

J Urol. 2002 Apr;167(4):1897-904.

Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation.

Cancer. 1997 Aug 15;80(4):764-75.

Influences of the Results from STRIVE Trial on the Combination Androgen Depletion Therapy for Advanced Prostate Cancer.

Curr Urol Rep. 2016 Nov;17(11):84. doi: 10.1007/s11934-016-0636-9.

引用本文的文献

Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade.

BMC Urol. 2023 Apr 28;23(1):74. doi: 10.1186/s12894-023-01233-6.

本文引用的文献

Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.

J Clin Oncol. 2009 Sep 10;27(26):4306-13. doi: 10.1200/JCO.2008.21.5228. Epub 2009 Aug 10.

Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.

Cancer. 2009 Aug 1;115(15):3376-8. doi: 10.1002/cncr.24393.

Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.

J Clin Oncol. 2007 Apr 20;25(12):1596-605. doi: 10.1200/JCO.2006.10.1949. Epub 2007 Apr 2.

Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patients.

Prostate Cancer Prostatic Dis. 2007;10(2):194-201. doi: 10.1038/sj.pcan.4500934. Epub 2007 Jan 2.

A re-assessment of the role of combined androgen blockade for advanced prostate cancer.

BJU Int. 2004 Jun;93(9):1177-82. doi: 10.1111/j.1464-410x.2004.04803.x.

Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Japanese patients.

Jpn J Clin Oncol. 2004 Jan;34(1):20-8. doi: 10.1093/jjco/hyh001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验